Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
EVFM
$57.50
EVFM
· Evofem Biosciences, Inc.
$57.50
At close · Aug 11
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has concluded that these circumstances and the uncertainties associated with the Company's ability to obtain additional equity or debt financing on terms that are favorable to the Company, or at all, and otherwise succeed in its future operations raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.06M
Shares
132.53M
Volume · Aug 11
58.6K
Avg daily vol (3M)
—
All webcasts
Earnings call · FY2021 Q4
Evofem Biosciences, Inc. (EVFM) Q4 2021 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$3.57M
+2025% YoY
Net income · derived Q4
-$51.55M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 3, 2022 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 10, 2022 · complete as-filed document